We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
DXB.AU

Price
0.42
Stock movement up
+0.01 (1.19%)
Company name
Dimerix Ltd
Exchange
(AU
,
Currency
AUD
)
Sector
Healthcare >
Biotechnology
Market cap
237.08M
Ent value
228.83M
Price/Sales
16.86
Price/Book
13.04
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
-
Forward P/E
-
PEG
-
EPS growth
33.17%
1 year return
44.07%
3 year return
40.12%
5 year return
24.03%
10 year return
11.71%
Last updated: 2025-04-18

DIVIDENDS

DXB.AU does not pay dividends or no data was received

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E-
Price to OCF-
Price to FCF-
Price to EBITDA-
EV to EBITDA-

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales16.86
Price to Book13.04
EV to Sales16.28

FINANCIALS

Per share

Loading...
Per share data
Current share count557.83M
EPS (TTM)-0.05
FCF per share (TTM)-0.04

Income statement

Loading...
Income statement data
Revenue (TTM)14.06M
Gross profit (TTM)14.06M
Operating income (TTM)-40.30M
Net income (TTM)-23.37M
EPS (TTM)-0.05
EPS (1y forward)-

Margins

Loading...
Margins data
Gross margin (TTM)100.00%
Operating margin (TTM)-286.65%
Profit margin (TTM)-166.20%

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash22.14M
Net receivables9.52M
Total current assets31.92M
Goodwill0.00
Intangible assets0.00
Property, plant and equipment223.51K
Total assets32.08M
Accounts payable305.16K
Short/Current long term debt149.68K
Total current liabilities3.36M
Total liabilities13.89M
Shareholder's equity18.19M
Net tangible assets0.00

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)-20.24M
Capital expenditures (TTM)18.10K
Free cash flow (TTM)-20.25M
Dividends paid (TTM)0.00

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity-128.49%
Return on Assets-72.84%
Return on Invested Capital-117.31%
Cash Return on Invested Capital-101.69%

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open0.42
Daily high0.43
Daily low0.41
Daily Volume1.05M
All-time high65.90
1y analyst estimate0.84
Beta0.50
EPS (TTM)-0.05
Dividend per share-
Ex-div date24 Sep 1999
Next earnings date21 Jul 2025

Downside potential

Loading...
Downside potential data
DXB.AUS&P500
Current price drop from All-time high-99.36%-14.12%
Highest price drop-99.91%-56.47%
Date of highest drop27 Jun 20239 Mar 2009
Avg drop from high-94.47%-11.07%
Avg time to new high270 days12 days
Max time to new high4536 days1805 days
COMPANY DETAILS
DXB.AU (Dimerix Ltd) company logo
Marketcap
237.08M
Marketcap category
Small-cap
Description
Dimerix Limited, a biopharmaceutical company, develops and commercializes pharmaceutical products for unmet medical needs in Australia. The company develops DMX-200, a Phase 3 clinical trial for focal segmental glomerulosclerosis disease; DMX-200 which is in phase 2 clinical trial for diabetic kidney disease; DMX-200 for ARDS associated with COVID-19; and DMX-700 for chronic obstructive pulmonary disease, as well as develops proprietary receptor- HIT assay technology. Dimerix Limited is headquartered in Fitzroy, Australia.
Employees
0
Investor relations
-
CEO
Country
Australia
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
No events found
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
No items found